UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 103.

Valet, S; Weisse, B; Fischer, B; Meyer, D C (2016). Mechanical effects of heat exposure from a bipolar radiofrequency probe on suture under simulated arthroscopic conditions. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 32(10):1985-1992.

Fischer, B; Frei, C; Moura, U; Stahel, R; Felley-Bosco, E (2012). Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy. Lung Cancer, 78(1):23-29.

Rehm, Jürgen; Frick, Ulrich; Fischer, B (2011). "Substanzgebrauchsstörungen" - ein neuer Ansatz im DSM 5? Sucht, 57(1):54-55.

Frei, C; Opitz, I; Soltermann, A; Fischer, B; Moura, U; Rehrauer, H; Weder, W; Stahel, R; Felley-Bosco, E (2011). Pleural mesothelioma side populations have a precursor phenotype. Carcinogenesis, 32(9):1324-1332.

Held, M; Schmitz, M H A; Fischer, B; Walter, T; Neumann, B; Olma, M H; Peter, M; Ellenberg, J; Gerlich, D W (2010). CellCognition: time-resolved phenotype annotation in high-throughput live cell imaging. Nature Methods, 7(9):747-754.

Fischer, B. Complications of robotic assited radical prostatectomy. 2010, University of Zurich, Faculty of Medicine.

Aberle, I; Scholz, Urte; Bach-Kliegel, C; Fischer, B; Gorny, M; Langer, K; Kliegel, M (2009). Psychological aspects in continuous subcutaneous insulin infusion: A retrospective study. Journal of Psychology, 143(2):147-160.

Rüegg, C; Fischer, B; Bächli, E; Gubler, C (2009). Flugzeuge im Bauch? Swiss Medical Forum, 9(10):217.

Eng, J K; Fischer, B; Grossmann, J; Maccoss, M J (2008). A fast SEQUEST cross correlation algorithm. Journal of Proteome Research, 7(10):4598-4602.

Fischer, B; Arcaro, A (2008). Current status of clinical trials for small cell lung cancer. Reviews on Recent Clinical Trials, 3(1):40-61.

Rehm, Jürgen; Fischer, B (2008). Should heroin be prescribed to heroin misusers? Yes. BMJ, 336:70.

Guerreiro, A S; Fattet, S; Fischer, B; Shalaby, T; Jackson, S P; Schoenwaelder, S M; Grotzer, M A; Delattre, O; Arcaro, A (2008). Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration. Clinical Cancer Research, 14(21):6761-6769.

Luu, V D; Fischer, B; von Teichman, A; Boysen, G; Mertz, K; Zimmermann, P; Moch, H; Schraml, P (2008). Von-Hippel-Lindau-Gen-Mutationstypen: Assoziation mit Genexpressionssignaturen in klarzelligen Nierenzellkarzinomen. Der Pathologe, 29(Suppl.):303-307.

Grossmann, J; Fischer, B; Baerenfaller, K; Owiti, J; Buhmann, J M; Gruissem, W; Baginsky, S (2007). A workflow to increase the detection rate of proteins from unsequenced organisms in high-throughput proteomics experiments. Proteomics, 7(23):4245-4254.

Reimer, J; Lorenzen, J; Baetz, B; Fischer, B; Rehm, Jürgen; Haasen, C; Backmund, M (2007). Multiple viral hepatitis in injection drug users and associated risk factors. Journal of Gastroenterology and Hepatology, 22:80-85.

Roos, F F; Jacob, R; Grossmann, J; Fischer, B; Buhmann, J M; Gruissem, W; Baginsky, S; Widmayer, P (2007). PepSplice: cache-efficient search algorithms for comprehensive identification of tandem mass spectra. Bioinformatics, 23(22):3016-3023.

Firestone Cruz, M; Fischer, B; Patra, J; Kalousek, K; Newton-Taylor, B; Rehm, Jürgen; Tyndall, M (2007). Prevalence and associated factors of Hepatitis C infection (HCV) in a multi-site Canadian population of illicit opioid and other drug users (OPICAN). Canadian Journal of Public Health. Revue Canadienne de Santé Publique, 98(2):130-133.

Fischer, B; Grossmann, J; Roth, V; Gruissem, W; Baginsky, S; Buhmann, J M (2006). Semi-supervised LC/MS alignment for differential proteomics. Bioinformatics, 22(14):e132-40.

Popova, S; Rehm, Jürgen; Fischer, B (2006). An overview of illegal opioid use and health services utilization in Canada. Disaster Medicine and Public Health Preparedness, 120(4):320-328.

Villeneuve, P; Challacombe, L; Strike, C; Myers, T; Fischer, B; Shore, R; Hopkins, S; Raftis, S; Millson, P (2006). Change in Health Related Quality of Life of Opiate Users in Low Threshold Methadone Programs. Journal of Substance Use, 11(2):137-149.

Fischer, B; Rehm, Jürgen; Patra, J; Firestone Cruz, M (2006). Changes in illicit opioid use profiles across Canada. Canadian Medical Association Journal = Journal de l'Association Medicale Canadienne, 75(11):1385-1387.

Fischer, B; Manzoni, P; Rehm, Jürgen (2006). Comparing injecting and non-injecting illicit opioid users in a multi-site Canadian sample (OPICAN cohort). European Addiction Research, 12(4):230-239.

Fischer, B; Rehm, Jürgen; Patra, J; Kalousek, K; Haydon, E; Tyndall, M; El-Guebaly, N (2006). Crack across Canada: Comparing crack and non-crack users in a multi-city cohort of opioid and other street drug users. Addiction, 101(12):1760-1770.

Manzoni, P; Brochu, S; Fischer, B; Rehm, Jürgen (2006). Determinants of Property Crime Among Illicit Opiate Users Outside of Treatment Across Canada. Deviant Behavior, 27(3):351-376.

Fischer, B; Popova, S; Rehm, Jürgen; Ivsins, A (2006). Drug-related overdose deaths in British Columbia and Ontario, 1992-2004. Canadian Journal of Public Health. Revue Canadienne de Santé Publique, 97(05):384-387.

Noël, L; Fischer, B; Bradet, R; Brissette, S; Brochu, S; Bruneau, J; Rehm, Jürgen; Tyndall, M; Wild, C; El-Guebaly, N (2006). Health and social services accessed by a cohort of Canadian illicit opioid users outside of treatment. Canadian Journal of Public Health. Revue Canadienne de Santé Publique, 97(3):166-170.

Fischer, B; Kalousek, K; Rehm, Jürgen; Powis, J; Krajden, M; Reimer, J (2006). Hepatitis C, illicit drug use and public health: Does Canada really have a viable plan? Canadian Journal of Public Health. Revue Canadienne de Santé Publique, 97(6):485-488.

Fischer, B; Firestone Cruz, M; Rehm, Jürgen (2006). Illicit opioid use and its key characteristics: A select overview and evidence from a Canadian multi-site cohort of illicit opioid users (OPICAN). Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 51(10):624-634.

Fischer, B; Rehm, Jürgen (2006). Illicit opioid use and treatment: Challenges for Canada and beyond (Editorial). Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 51(10):621-623.

Rehm, Jürgen; Baliunas, D; Brochu, S; Fischer, B; Gnam, W; Patra, J; Popova, S; Sarnocinska-Hart, A; Taylor, B (2006). The costs of substance abuse in Canada 2002. Ottawa and Canada: Canadian Centre on Substance Abuse.

Fischer, B; Rodopulos, J; Rehm, Jürgen; Ivsins, A; Rodopoulos, J (2006). Toking and driving: Characteristics of Canadian university students who drive after cannabis use---an exploratory pilot study. Drugs, 13(02):179-187.

Fischer, B; Reimer, J; Firestone Cruz, M; Kalousek, K; Rehm, Jürgen; Heathcote, J (2006). Treatment for hepatitis C virus (HCV) and cannabis use in illicit drug user patients: questions and implications. European Journal of Gastroenterology and Hepatology, 18(10):1039-1042.

Fischer, B; Vasdev, S; Haydon, E; Baliunas, D; Rehm, J (2005). Acceptabilite d'un traitement du virus de l'hepatite C chez les utilisateurs de drogues injectables au Canada. La Presse Médicale, 34:1209-1212.

Wild, C; El-Guebaly, N; Fischer, B; Brissette, S; Brochu, S; Bruneau, J; Noël, L; Rehm, J; Tyndall, M; Mun, P (2005). Comorbid Depression Among Untreated Illicit Opiate Users: Results From a Multisite Canadian Study. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 50(09):512-518.

Haydon, E; Fischer, B (2005). Crack use as a public health problem in Canada: call for an evaluation of 'safer crack use kits'. Canadian Journal of Public Health. Revue Canadienne de Santé Publique, 96(3):185-188.

Fischer, B (2005). Dealing with prostitution. Canadian Medical Association Journal = Journal de l'Association Medicale Canadienne, 172(1):13-14.

Fischer, B; Monga, N; Manzoni, P (2005). Differences between co-users of cocaine and crack among Canadian illicit opioid users. Suchtforschung des BAG, 51(4):217-224.

Lengler, R; Rehm, Jürgen; Uchtenhagen, Ambros; Fischer, B; Bolliger, Heidi (2005). Erhebung des Behandlungsbedarfs von Personen mit primärer Opioidabhängigkeit im Kanton Tessin. In: Bundesamt für Gesundheit. Suchtforschung des BAG / Recherches de l'OFSP en matière de dépendances. Bern: Bundesamt für Gesundheit, 46-53.

Fischer, B; Rehm, J; Kim, G; Kirst, M (2005). Eyes wide shut? A conceptual and empirical critique of methadone maintenance treatment. European Addiction Research, 11(1):1-12.

Strike, C; Gnam, W; Urbanoski, K; Fischer, B; Marsh, D C; Millson, M (2005). Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence. Psychology of Addictive Behaviors, 30(5):1025-1028.

Farley, J; Vasdev, S; Fischer, B; Haydon, E; Rehm, J; Farley, T A (2005). Feasibility and outcome of HCV treatment in a Canadian federal prison population. American Journal of Public Health, 95(10):1737-1739.

Fischer, B (2005). Harm Reduction. In: Canadian Centre on Substance Abuse. Substance Use in Canada: Current Challenges and Choices. Ottawa: Canadian Centre on Substance Abuse, 11-16.

Farley, J; Vasdev, S; Fischer, B; Rehm, J (2005). Hepatitis C treatment in a Canadian federal correctional population: Preliminary feasibility and outcomes. International Journal of Prisoner Health, 1(1):13-18.

Rehm, J; Single, E; Fischer, B (2005). Heroin prescription and public health. Epidemiological considerations and the need for evidence-based cost-effective Interventions. In: Rihs-Middel, M; Hammig, R; Jacobshagen, N. Heroin-assisted treatment. Work in progress. Bern: Huber, 365-373.

Fischer, B; Rehm, J; Brissette, S; Brochu, S; Bruneau, J; El-Guebaly, N; Noël, L; Tyndall, M; Wild, C; Mun, P; Baliunas, D (2005). Illicit opioid use in Canada: Comparing social, health and drug use characteristics of untreated users in five cities (OPICAN study). Journal of Urban Health: Bulletin of the New York Academy of Medicine, 82(2):250-266.

Fischer, B; Roth, V; Roos, F; Grossmann, J; Baginsky, S; Widmayer, P; Gruissem, W; Buhmann, J M (2005). NovoHMM: a hidden Markov model for de novo peptide sequencing. Analytical Chemistry, 77(22):7265-7273.

Fischer, B (2005). Opiate Addiction Treatment, Research and Policy in Canada - Past, Present and Future Issues. In: Rihs-Middel, M; Hämmig, R; Jacobshagen, N. Heroin-assisted treatment. Work in progress. Bern: Huber, 331-346.

Leri, F; Stewart, J; Fischer, B; Rehm, J; Brissette, S; Brochu, S; Bruneau, J; El-Guebaly, N; Noel, L; Tyndall, M; Wild, C (2005). Patterns of opioid and cocaine co-use: A descriptive study in a Canadian sample of untreated opioid-dependent individuals. Experimental and Clinical Psychopharmacology, 13(4):303-310.

Strike, C; Urbanoski, K; Fischer, B; Marsh, D; Millson, P (2005). Policy Changes and the Methadone Maintenance Treatment System for Opioid Dependence in Ontario, 1996 to 2001. Journal of addictive diseases, 24(01):39-51.

Haydon, E; Rehm, J; Fischer, B; Monga, N; Adlaf, E (2005). Prescription drug abuse in Canada and the diversion of prescription drugs into the illicit drug market. Canadian Journal of Public Health. Revue Canadienne de Santé Publique, 96(6):459-461.

Rehm, J; Fischer, B; Graham, K; Haydon, E; Mann, R E; Room, R (2004). The importance of environmental modifiers of the relationship between substance use and harm. Open Addiction Journal, 99(6):663-666.

Fischer, B; Brissette, S; Brochu, S; Bruneau, J; El-Guebaly, N; Noel, L; Rehm, J; Tyndall, M W; Wild, C; Mun, P; Haydon, E; Baliunas, D (2004). Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. Canadian Medical Association Journal = Journal de l'Association Medicale Canadienne, 171(03):235-239.

Fischer, B; Turnbull, S; Poland, B; Haydon, E (2004). Drug use, risk and urban order: examining supervised injection sites (SISs) as ‘governmentality’. International Journal of Drug Policy, 15:357-365.

Myers, T; Aguinaldo, J P; Fischer, B; Bullock, S; Dakers, D; Leaver, C; Millson, P; Calzavara, L (2004). How drug using men who have sex with men account for substance use during sexual behaviours: Questioning assumptions of HIV prevention and research. Addiction Research and Theory, 12(03):213-229.

Fischer, B; Haydon, E; Rehm, J; Krajden, M; Reimer, J (2004). Injection drug use and the hepatitis C virus: considerations for a targeted treatment Approach - the case study of Canada. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 81(03):428-447.

Millson, P; Challacombe, L; Villeneuve, P J; Fischer, B; Strike, C J; Myers, T (2004). Self-perceived health among Canadian opiate users: a comparison to the general population and to other chronic disease populations. Canadian Journal of Public Health. Revue Canadienne de Santé Publique, 95(2):99-103.

Rehm, Jürgen; Frick, Ulrich; Fischer, B (2004). Zur Ökonomie des Suchtmittelgebrauchs. In: Tretter, F; Erbas, B; Sonntag, G. Oekonomie der Sucht und Suchttherapie. Lengerich and Berlin: Pabst, 233-244.

Fischer, B (2003). 'Doing good with a vengeance': a critical assessment of the practice, effects and implications of 'drug treatment courts' in North America. Criminal Justice History, 3(3):227-248.

Rehm, Jürgen; Fischer, B; Frick, Ulrich (2003). 'Public Health' und ökonomische Studien im Bereich Sucht. Suchttherapie, 4(1):1.

Rehm, J; Fischer, B; Haydon, E; Room, R (2003). Abstinence ideology and somatic treatment for addicts - ethical considerations. Editorial. Addiction Research and Theory, 11(5):287-293.

Fischer, B; Ala-Leppilampi, K; Single, E; Robins, A (2003). Cannabis law reform in Canada: is the 'saga of promise, hesitation and retreat' coming to an end? Canadian Journal of Criminology and Criminal Justice, 45(3):265-297.

Crofts, N (2003). Complacency as a barrier to effective prevention, treatment and policy of HIV/AIDS and IDU. In: Fischer, B; Rehm, J; Haydon, E. Reducing the Risks, Harms and Costs of HIV/AIDS and Injection Drug Use: A Synthesis of the Evidence Base for Development of Policies and Programs. Background paper #4, 2nd Annual Background Dialogue on HIV/AIDS. Warsaw: Health Canada/UNAIDS/Canadian International Development Agency, n/a.

Dolan, K (2003). IDU and HIV/AIDS risk reduction, prevention and treatment measures for prison populations. In: Fischer, B; Rehm, J; Haydon, E. Reducing the risks, harms and costs of HIV/AIDS and injecting drug use: a synthesis of the evidence base for development of policies and programs. Ottawa: Health Canada, n/a.

Fischer, B (2003). Illegale Opiatsucht, Behandlung und ökonomische Kostenforschung - Überblick und Diskussion aus sozialwissenschaftlicher Perspektive. Suchttherapie, 4(1):2-7.

Rehm, Jürgen; Lengler, R; Bolliger, Heidi; Uchtenhagen, Ambros; Fischer, B (2003). Rilevamento del fabbisogno di trattamento per persone con problemi primari in relazione al consumo di oppiacei nel Canton Ticino. Rapporto finale. Zurich: Swiss Research Institute for Public Health and Addiction.

Fischer, B (2003). Safe injection sites - Will secure facilities protect drug users from disease? Parkhust Exchange, 11(4):24.

Fischer, B; Haydon, E; Kim, G; Rehm, J; El-Guebaly, N (2003). Screening for antisocial personality disorder in drug users — A qualitative exploratory study on feasibility. International Journal of Methods in Psychiatric Research, 12(3):151-156.

Haydon, E; Fischer, B; Rehm, J (2003). Social determinants of injection drug use and HIV/AIDS. In: Rehm, J; Fischer, B; Haydon, E. Reducing the risks, harms and costs of HIV/AIDS and injecting drug use: a synthesis of the evidence base for development of policies and programs. Ottawa: s.n., n/a.

Strathdee, S (2003). The international epidemiology and burden of disease of injection drug use and HIV/AIDS. In: Rehm, J; Fischer, B; Haydon, E. Reducing the risks, harms and costs of HIV/AIDS and injecting drug use: a synthesis of the evidence base for development of policies and programs. Ottawa: Health Canada, n/a.

Fischer, B; Brissette, S; Brochu, S; Bruneau, J; El-Guebaly, N; Noel, L; Rehm, J; Tyndall, M (2002). 'OPICAN': a multisite cohort study of untreated illicit opiate users in Canada. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 79(Suppl.1):S69.

Fischer, B; Chin, A; Kuo, I; Kirst, M; Vlahov, D (2002). Canadian illicit opiate users' views on methadone and other opiate prescription treatment: an exploratory qualitative study. Substance Use and Misuse, 37(4):495-522.

Fischer, B; Roberts, J V; Kirst, M (2002). Compulsory drug treatment in Canada: historical origins and recent developments. European Addiction Research, 8(2):61-68.

Fischer, B; Rehm, Jürgen; Uchtenhagen, Ambros; Kirst, M (2002). Compulsory treatment - what do we know and where should we go? Editorial. European Addiction Research, 8(2):52-53.

Fischer, B; Room, R; Ala-Leppilampi, K (2002). Control of cannabis use in western countries - A brief review of history and present. In: Ministry of Justice. European City Conference on Cannabis Policy - Conference Book. The Hague: s.n., 37-42.

Rehm, J; Fischer, B; Krausz, M (2002). Heroin prescription for opioid addicts. Authors' reply. Lancet, 359(9309):390.

Fischer, B; Rehm, Jürgen; Kirst, M; Casas, M; Hall, W; Krausz, M; Metrebian, N; Reggers, J; Uchtenhagen, Ambros; van den Brink, W; van Ree, J (2002). Heroin-assisted treatment as a response to the public health problem of opiate dependence. European Journal of Public Health, 12(3):228-234.

Warner, J; Fischer, B; Albanes, R; Amitay, O (2002). Marijuana, juveniles and the police: what high-school students believe about detection and enforcement. In: Fleming, T; O'Reilly, P; Clark, B. Youth injustice: Canadian perspectives. Toronto: Canadian Scholars' Press, n/a.

Fischer, B; Bisceglia, D; Daniel, N; Gliksman, L (2002). Methadone treatment in Ontario after the 1996 regulation reforms. Results of a physician survey. Annales de Medecine Interne, 153(S7):2S11-2S21.

Fischer, B; Rehm, J; Kim, G; Robins, A (2002). Safer injection facilities (SIFs) for injection drug users (IDUs) in Canada. A review and call for an evidence-focused pilot trial. Canadian Journal of Public Health. Revue Canadienne de Santé Publique, 93(5):336-338.

Bell, J; Dru, A; Fischer, B; Levit, S; Sarfraz, M A (2002). Substitution therapy for heroin addiction. Substance Use and Misuse, 37(8-10):1149-1178.

Fischer, B; Wortley, S; Webster, C; Kirst, M (2002). The socio-legal dynamics and implications of 'diversion': the case study of the Toronto 'John School' diversion program for prostitution offenders. Criminology & Criminal Justice, 2(4):385-410.

Wortley, S; Fischer, B; Webster, C (2002). Vice lessons: a survey of prostitution offenders enrolled in the Toronto John School Diversion Program. Canadian Journal of Criminology and Criminal Justice, 44(4):369-402.

Rehm, J; Fischer, B (2002). Von kontrollierten klinischen Studien zu einer Gestaltung des Behandlungssytems für Suchtkranke. Sucht, 48(03):310-311.

Fischer, B (2001). Community policing - Some observations and reflections on its social, legal and democratic implications. In: Einstein, S; Amir, M. Policing, security and democracy: special aspects of 'democratic policing'. Huntsville: Office of International Criminal Justice, 35-60.

Fischer, B; Medved, W; Kirst, M; Rehm, J; Gliksman, L (2001). Illicit opiates and crime: Results of an untreated user cohort study in Toronto. Canadian Journal of Criminology and Criminal Justice, 43(02):197-217.

Fischer, B; Rehm, J (2001). Some reflections on the relationship of risk, harm and responsibility in recent tobacco lawsuits, and implications for public health. Canadian Journal of Public Health. Revue Canadienne de Santé Publique, 92(1):7-8.

Kirst, M; Fischer, B (2001). Usage des drogues injectables - Apercu de la situation au Canada. La Revue des Addictions, 10(03):594-600.

Kuo, I; Fischer, B; Vlahov, D (2000). Consideration of a North American heroin-assisted trial for the treatment of opiate-dependent individuals. International Journal of Drug Policy, 11(5):357-370.

Rehm, J; Fischer, B (2000). Heroingestützte Therapie für Opiatabhängige - weder Allheilmittel noch Teufelswerk. Suchttherapie, 01(02):57-62.

Fischer, B; Rehm, J; Blitz-Miller, T (2000). Injection drug use and preventive measures: A comparison of Canadian and Western European jurisdictions over time. Canadian Medical Association Journal = Journal de l'Association Medicale Canadienne, 162(12):1709-1713.

Rehm, J; Fischer, B (2000). Kosten, Nutzen und Effizienz der Opiatsubstitution. In: Zerdick, J. Suchtmedizin im Dialog. Berlin: Verlag für Wissenschaft und Bildung, 71-78.

Fischer, B (2000). Prescriptions, power and politics: The turbulent history of methadone maintenance in Canada. Journal of Public Health Policy, 21(2):187-210.

Wall, R; Rehm, J; Fischer, B; Brands, B; Gliksman, L; Stewart, J; Medved, W; Blake, J (2000). Social costs of untreated opioid dependence. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 77(4):688-722.

Fischer, B; Kirst, M; Rehm, J; Marsh, D; Bondy, S; Tyndall, M (2000). The phenomenon of so-called 'other drug use' among opiate addicts in the North American context: Evidence, consequences, questions. In: Jellinek, C; Westermann, B; Bellmann, G. Beigebrauch: Offene Grenzen der Substitution. Weinheim: Deutscher Studienverlag, 95-117.

Fischer, B; Rehm, J (1999). Argumentos a favor de un ensayo de tratamiento de sustitución con heroína en Canadá. In: Inchaurraga, S. Drogas y políticas públicas : El modelo de la reducción de daños Drugs and public policies: The 'harm reduction' model. Rosario: Universidad de Rosario, 105-117.

Fischer, B; Gliksman, L; Rehm, J; Daniel, N; Medved, W (1999). Comparing opiate users in methadone treatment with untreated opiate users: results of a follow-up study with a Toronto opiate user cohort. Canadian Journal of Public Health. Revue Canadienne de Santé Publique, 90(5):299-303.

Fischer, B (1999). Heroinabhängigkeit, Behandlung und Politik in Kanada - Geschichte, Gegenwart und Perspektiven für einen Heroinverschreibungs-Versuch. In: Westermann, B; Bellmann, G; Jellinek, C. Heroinverschreibung - Wirkungen und Nebenwirkungen. Weinheim: Deutscher Studien Verlag, 35-46.

Fischer, B (1999). Heroinsucht und Behandlungspolitik in Kanada - Entschiedene Schritte nach vorne oder 'Back to the Future'? Akzeptanz 4, University of Zurich.

Fischer, B; Medved, W; Gliksman, L; Rehm, J (1999). Illicit opiates in Toronto: a profile of current users. European Addiction Research, 7(5):377-415.

Fischer, B (1999). Prohibition, public health and a window of opportunity: an analysis of Canadian drug policy, 1985-1997. Policy Studies, 20(3):197-210.

Fischer, B; Rehm, J (1996). Alcohol consumption and the liability of offenders in the German criminal system. Contemporary Drug Problems, 23(Winter):707-729.

Fischer, B; Erickson, P; Smart, R (1996). The new Canadian drug law Bill C-7: one step forward, two steps backward. International Journal of Drug Policy, 07(03):172-179.

Fischer, B (1995). Drugs, communities and 'harm reduction' in Germany: the new relevance of 'public health' principles in local responses. Journal of Public Health Policy, 16(4):389-411.

This list was generated on Fri Jul 21 05:28:16 2017 CEST.